Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type...

por Warren, Mark L., Chaykin, Louis B., Jabbour, Serge, Sheikh-Ali, Mae, Hansen, Charlotte T., Nielsen, Thor S.S., Norwood, Paul
Publicado 2017

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III...

por Linjawi, Sultan, Bode, Bruce W., Chaykin, Louis B., Courrèges, Jean-Pierre, Handelsman, Yehuda, Lehmann, Lucine M., Mishra, Abhishek, Simpson, Richard W.
Publicado 2016